HopeStage
Back to all studies
RecruitingNCT07616999

Twenty-year follow-up after a first episode of psychosis

About this titleRead the official source — NCT07616999
Observational studyAges 18–65ChinaSchizophrenia
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

What will I do during this study?

You will take part in a one-time, in-person assessment with a trained research assistant. It includes questions about your background, symptoms, daily life, thinking and wellbeing, as well as structured clinical interviews and cognitive tests.

Listed locations
Hong KongSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 21, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
178
Sponsor
The University of Hong Kong
Sponsor type
University
Study type
Observational
Intervention type
Interview / survey / observational
Study phase
Not clearly listed
Locations
China
Age range
From 18 Years to 65 Years
Official registry ID
NCT07616999
Official title
Show the full official title

Navigating the Longitudinal Effects of Early Treatment Strategies and Relapse on Clinical, Cognitive, and Functional Outcomes: A 20-Year Follow-up of First Episode Psychosis

Recruitment & locations

Currently recruiting

Hong Kong

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is The University of Hong Kong, a university.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies